|
[1]
|
Sung, H., Ferlay, J., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Youn, H.J. and Han, W. (2020) A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors. Asian Pacific Journal of Cancer Prevention, 21, 867-880. [Google Scholar] [CrossRef]
|
|
[3]
|
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F. and Woller, N. (2018) CD4 and CD8 T Lymphocyte Interplay in Controlling Tumor Growth. Cellular and Molecular Life Sciences, 75, 689-713. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhao, L., Lian, T., Li, J., Wei, S., Li, H., Li, C. and Wang, H. (2021) NCR3LG1 (B7-H6) Is a Potential Prognostic Factor for Bladder Cancer Patients. Biomarkers, 26, 260-267. [Google Scholar] [CrossRef]
|
|
[5]
|
Miksch, R.C., Schoenberg, M.B., Weniger, M., Bösch, F., Ormanns, S., Mayer, B., Werner, J., Bazhin, A.V. and D’haese, J. (2019) Prognostic Impact of Tumor-Infiltrating Lym-phocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer. Cancers, 11, Article 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chen, L., Kong, X.Y., et al. (2020) The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer. OncoTargets and Therapy, 13, 1397-1412. [Google Scholar] [CrossRef]
|
|
[7]
|
Yu, W., Wang, Y. and Guo, P. (2018) Notch Signaling Pathway Dampens Tumor-Infiltrating CD8+ T Cells Activity in Patients with Colorectal Carcinoma. Biomedicine Pharmacothera-py, 97, 535-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Li, M., Yao, D., Zeng, X., et al. (2019) Age Related Human T Cell Subset Evolution and Senescence. Immunity & Ageing, 16, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ruterbusch, M., Pruner, K.B., Shehata, L. and Pepper, M. (2020) In Vivo CD4+ T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm. Annual Review of Immunology, 38, 705-725. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Rodriguez-Vida, A., Bamias, A., et al. (2020) Randomised Phase II Study Comparing Alternating Cycles of Sunitinib and Everolimus vs Standard Sequential Admin-istration in First-Line Metastatic Renal Carcinoma (SUNRISES Study). BJU International, 126, 559-567. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Khan, M., Arooj, S. and Wang, H. (2020) NK Cell-Based Immune Check-point Inhibition. Frontiers in Immunology, 11, Article 488471. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tanaka, J. and Miller, J.S. (2020) Recent Progress in and Chal-lenges in Cellular Therapy Using NK Cells for Hematological Malignancies. Blood Reviews, 44, Article ID: 100678. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Devillier, R., Chrétien, A.S., et al. (2020) Mechanisms of NK Cell Dysfunction in the Tumor Microenvironment and Current Clinical Approaches to Harness NK Cell Potential for Immu-notherapy. Journal of Leukocyte Biology, 109, 1071-1088. [Google Scholar] [CrossRef]
|
|
[14]
|
Qiu, Y., Li, H., Zhang, Q., et al. (2022) Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adeno-carcinoma. Applied Bionics and Biomechanics, 2022, Article ID: 5220368. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Galeano Niño, J.L., Pageon, S.V., et al. (2020) Cytotoxic T Cells Swarm by Homotypic Chemokine Signalling. elife, 9, e56554. [Google Scholar] [CrossRef]
|
|
[16]
|
Xie, J., Chen, L., Sun, Q., et al. (2022) An Immune Subtype-Related Prognostic Signature of Hepatocellular Carcinoma Based on Single-Cell Sequencing Analysis. Aging, 14, 3276-3292. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liu, A., Xia, Y., Li, et al. (2022) The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients. Contrast Media & Molecular Imaging, 2022, Article ID: 3444360. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ethier, J.L., Desautels, D., Templeton, A., Shah, P.S. and Amir, E. (2017) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Breast Cancer: A Systematic Review and Meta-Analysis. Breast Cancer Research, 19, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Goto, W., Kashiwagi, S., et al. (2018) Predictive Value of Lym-phocyte-to-Monocyte Ratio in the Preoperative sEtting for Progression of Patients with Breast Cancer. BMC Cancer, 18, Article No. 1137. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zander, R., Schauder, D., et al. (2019) CD4+ T Cell Help Is Re-quired for the Formation of a Cytolytic CD8+ T Cell Subset That Protects against Chronic Infection and Cancer. Immunity, 51, 1028-1042.E4. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Omilusik, K.D. and Goldrath, A.W. (2019) Remembering to Remember: T Cell Memory Maintenance and Plasticity. Current Opinion in Immunology, 58, 89-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Mazet, J.M., Mahale, J.N., et al. (2023) IFNγ Signaling in Cytotoxic T Cells Restricts Anti-Tumor Responses by Inhibiting the Maintenance and Diversity of Intra-Tumoral Stem-Like T Cells. Nature Communications, 14, Article No. 321. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Xie, L., Fang, J., Yu, J., et al. (2023) The Role of CD4+ T Cells in Tumor and Chronic Viral Immune Responses. MedComm, 4, e390. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Fu, J., Yu, A., Xiao, X., et al. (2020) CD4+ T Cell Exhaustion Leads to Adoptive Transfer Therapy Failure Which Can Be Prevented by Immune Checkpoint Blockade. American Journal of Cancer Research, 10, 4234-4250.
|
|
[25]
|
Riazi Rad, F., Ajdary, S., et al. (2015) Comparative Analysis of CD4+ and CD8+ T Cells in Tumor Tissues, Lymph Nodes and the Peripheral Blood from Patients with Breast Cancer. Iranian Biomedical Journal, 19, 35-44.
|
|
[26]
|
贡鸣, 何天宇, 裘敬平, 等. 6种常见肿瘤患者初治时外周血T淋巴细胞亚群数量及临床特征[J]. 中国医科大学, 2018, 47(12): 1119-1122.
|
|
[27]
|
龚莉, 许觉彬. 癌症患者淋巴细胞亚群检测的临床意义[J]. 系统医学, 2018, 3(4): 124-125.
|
|
[28]
|
侯明生, 王宁, 等. CD3+, CD4+, CD8+淋巴细胞和血小板水平与乳腺癌的关系[J]. 中国妇幼健康研究2018, 29(12): 1548-1552.
|
|
[29]
|
林永忠, 陈榕. 乳腺癌患者手术前后外周血CD4+和CD8+及Treg细胞的表达及临床意义[J]. 当代医学, 2019, 25(29): 78-81.
|
|
[30]
|
Huang, Y., Ma, C., et al. (2015) CD4+ and CD8+ T Cells Have Opposing Roles in Breast Cancer Progression and Outcome. Oncotarget, 6, 17462-17478. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Yılmaz, M. and Durusoy, S.S. (2023) TCL-120 Face and Neck Cu-taneous T-Cell Lymphomatoid Papulosis: Case Report. Clinical Lymphoma, Myeloma and Leukemia, 23, S465-S465. [Google Scholar] [CrossRef]
|
|
[32]
|
Goff, S.L. and Danforth, D.N. (2021) The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer. Clinical Breast Cancer, 21, E63-E73. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Wang, G., Zhang, Z., et al. (2022) CXCL11-Armed Oncolytic Ad-enoviruses Enhance CAR-T Cell Therapeutic Efficacy and Reprogram Tumor Microenvironment in Glioblastoma. Mo-lecular Therapy, 31, 134-153. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Lam, B.M. and Verrill, C. (2023) Clinical Significance of Tu-mour-Infiltrating B Lymphocytes (TIL-Bs) in Breast Cancer: A Systematic Literature Review. Cancers, 15, Article 1164. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Gu-Trantien, C., Loi, S., et al. (2013) CD4+ Follicular Helper T Cell Infiltration Predicts Breast Cancer Survival. The Journal of Clinical Investigation, 123, 2873-2892. [Google Scholar] [CrossRef]
|
|
[36]
|
Mohammed, Z.M., et al. (2013). The Relationship between Lymphocyte Subsets and Clinico-Pathological Determinants of Survival in Patients with Primary Operable Invasive Ductal Breast Cancer. British Journal of Cancer, 109, 1676-1684.[CrossRef] [PubMed]
|
|
[37]
|
Mahmoud, S.M., Lee, A.H., et al. (2011) The Prognostic Significance of B Lymphocytes in Invasive Carcinoma of the Breast. Breast Cancer Research and Treatment, 132, 545-553. [Google Scholar] [CrossRef] [PubMed]
|